AffiVIR
  • Shop
  • News
  • 0
  • 0
  • (800) 660-1620
  • Sign in
  • Contact Us
AffiVIR
  • 0
  • 0
    • Shop
    • News
  • (800) 660-1620
  • Sign in
  • Contact Us
AffiVIR News
 
Team
Control A Comprehensive Technical Analysis :AffiVIR® GFP Lentivirus Control
In the realm of molecular biology and genetic engineering, lentiviral vectors have emerged as indispensable tools for the delivery and manipulation of genetic material. Among these vectors, AffiVIR® G...
May 3, 2024
Team
Characterization of AffiVIR® rVSV Pseudotyped EBOV GP: A Tool for Ebola Virus Entry Studies
This study aims to characterize the properties of AffiVIR® rVSV pseudotyped with the Ebola virus glycoprotein (EBOV GP). The AffiVIR® platform holds promise for vaccine development and therapeutic int...
May 3, 2024
Team
Development and Characterization of AffiVIR® rVSV Pseudotyped with MARV GP for Enhanced Therapeutic Efficacy
In the realm of viral vector-based therapeutics, the utilization of recombinant vesicular stomatitis virus (rVSV) pseudotyped with Marburg virus glycoprotein (MARV GP) holds significant promise for ta...
May 3, 2024
Team
Engineering AffiVIR® rVSV Pseudotyped with SUDV GP: A Technical Approach for Vaccine Development"
This study focuses on the development and characterization of AffiVIR® rVSV pseudotyped with the glycoprotein (GP) of Sudan virus (SUDV) for potential vaccine applications. The AffiVIR® platform offer...
May 3, 2024
  • Home
  • About us
  • Products
  • Blog
  • Privacy Policy
Follow us
Get in touch
Copyright © AffiGEN Inc.
Powered by Odoo - The #1 Open Source eCommerce

We use cookies to provide you a better user experience on this website. Cookie Policy

Only essentials I agree